Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fluxaparide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 2-trifluoromethyl[1,2,4]triazolo[1,5-a]pyrazine via patent CN111635407B. Offers high yield, safer solvents, and cost reduction in API manufacturing for PARP inhibitors.
Patent CN111732594A reveals a cost-effective 3-step route for Fluzoparib, eliminating Pd/C hydrogenation and expensive coupling reagents for scalable manufacturing.